VANCOUVER, British Columbia, March 05, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV; FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, is pleased to announce closing of its previously announced non-brokered private placement of convertible debenture units (“Debenture Units”) for aggregate gross proceeds of $1,000,000 […]
Wet February leads to plunge in shopping trips
...
Read moreDetails
